Psychiatry and Mental Health

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Peter Whitehouse, MD, PhD

Guest: Daniel George, MSc, PhD

Although there’s still no cure for Alzheimer’s disease, we’ve made great strides in understanding the tragic disease that affects more than 50 million people worldwide. So what are the latest updates in treating and alleviating this disease? To learn more about what’s new in Alzheimer’s disease research, Dr. Jerome Lisk speaks with Dr. Peter Whitehouse and Dr. Daniel George, co-authors of American Dementia: Brain Health in an Unhealthy Society.

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Peter Whitehouse, MD, PhD

The FDA’s recent approval of aducanumab for the treatment of Alzheimer’s disease has been met with a controversial response. So what do we need to know about this new drug and its potential to treat this progressive neurological disorder? Dr. Jerome Lisk is joined by Dr. Peter Whitehouse from Case Western Reserve University to break down the approval of this new drug and what it could mean for patients.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Margaret Chisolm, MD

The Diagnostic and Statistical Manual of Mental Disorders (DSM) is the handbook traditionally used by healthcare professionals to guide the diagnosis of psychiatric conditions, but a number of psychiatrists advocate for the perspectives approach, which extends beyond the DSM model. So how exactly do these two models differ? And how might this newer approach impact our patients? Joining Dr. Charles Turck to answer those and other key questions on the perspectives approach to diagnosing and treating patients with mental illness is Dr. Margaret Chisolm, author of From Survive to Thrive: Living Your Best Life with Mental Illness.

Host: Hector O. Chapa, MD, FACOG

Guest: Kellie Moore, ND

We've all heard the phrase "you are what you eat." But are we now at a point where science is backing up that old saying? To find out how our diet can impact our cognitive function and mood, Dr. Hector Chapa speaks with naturopathic physician Dr. Kellie Moore. Together, they’ll review the foods that we should eat versus avoid and the resources we can use to help our patients have a healthy mind and body.

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"

Guest: Jose Rubio, MD

Schizophrenia is rarely a single-episode illness. In fact, 8 out of 10 patients will experience a relapse of symptoms after initial treatment. So how can we help reduce the frequency of relapse—and even non-adherence—among our patients with schizophrenia? To find out, Dr. Andrew Wilner is joined by Dr. Jose Rubio, psychiatrist at Long Island Jewish Medical Center and Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, to talk about the use of long-acting injectable (LAI) antipsychotics for schizophrenia treatment.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Emily Carroll, JD, MSW

The No Surprises Act aims to protect consumers from surprise medical bills. But how exactly does it go about doing that, and what’s the current status of its implementation? Joining Dr. Charles Turck to share progress and challenges associated with the No Surprises Act is Ms. Emily Carroll, a senior legislative attorney for the American Medical Association's Advocacy Resource Center.

Host: Jerome Lisk, MD, MBA, M.S., FAAN

Guest: Tissa Wijeratne MD PhD FRACP FRCP FAAN

Since the onset of the COVID-19 pandemic, researchers and clinicians alike have strived to address the mysteries surrounding the virus, including its long-term side effects on patients. So what we do need to know about the emerging syndrome pointing to COVID-19’s neurological and cognitive impacts? To find out, Dr. Jerome Lisk is joined by Dr. Tissa Wijeratne, the Director of the Department of Neurology and Stroke Services at the University of Melbourne, to talk about post-COVID-19 neurological syndrome.

Host: Hector O. Chapa, MD, FACOG

Guest: Shay Walters

Mrs. Shay Walters was just 15 years old when she first became involved with substance use, and it wouldn’t be until years later that she would finally overcome her addiction. Her story, however, is far from the only one like it. Millions of Americans currently struggle with addiction, which is why she founded the “From Prison to Purpose” Facebook group that now has half a million followers. And to further help those who are trapped under drug addiction and even the clinicians who care for those patients, Mrs. Walters joins Dr. Hector Chapa to share her inspiring story.

Host: Andrew Wilner, MD, Author of "The Locum Life: A Physician's Guide to Locum Tenens"

Guest: Nicola Cascella, MD

Although there’s currently no cure for schizophrenia, it can be managed with therapy and medication—for some patients, that is. In fact, up to one-half of patients with severe symptoms don’t respond to medication. So how are we to care for this large percentage of patients living with treatment-resistant schizophrenia? That’s the question Dr. Andrew Wilner asks Dr. Nicola Cascella, an Assistant Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University School of Medicine who recently conducted a case study exploring the potential use of deep brain stimulation for patients with treatment-resistant schizophrenia.

Host: Charles Turck, PharmD, BCPS, BCCCP

Guest: Gail Saltz, MD

The quarantine blues may have come to an end, but as the country continues to reopen, a whole new set of mental health challenges are just beginning. So how can we help our patients who found comfort in social distancing and mask-wearing mandates navigate this change and return to public places? To find out, Dr. Charles Turck speaks with psychiatrist Dr. Gail Saltz, who discusses the lasting effects of the quarantine blues, how we can help patients who are suffering from anxiety, and more.